At close: December 13 at 4:00:01 PM EST
After hours: 7:00:41 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
11,785.9250
11,457.0610
20,257.2880
11,566.9600
6,436.8590
Operating Income
-11,785.9250
-11,457.0610
-20,257.2880
-11,566.9600
-6,436.8590
Net Non Operating Interest Income Expense
259.5840
335.5410
101.2020
11.6270
-277.9480
Other Income Expense
--
--
-7,268.1430
-402.8120
-8,700.0000
Pretax Income
-11,526.3410
-11,121.5200
-27,424.2290
-11,958.1450
-15,414.8070
Tax Provision
-181.7520
--
--
-530.6110
-1,001.0190
Net Income Common Stockholders
-11,526.3410
-11,121.5200
-27,424.2290
-11,427.5340
-19,039.7360
Diluted NI Available to Com Stockholders
-11,526.3410
-11,121.5200
-27,424.2290
-11,427.5340
-19,039.7360
Basic EPS
-4.80
-8.48
-34.05
-15.00
-50.80
Diluted EPS
-4.80
-8.48
-34.05
-15.00
-50.80
Basic Average Shares
2,534.5540
1,311.5720
805.4770
765.9730
374.9830
Diluted Average Shares
2,534.5540
1,311.5720
805.4770
765.9730
374.9830
Total Operating Income as Reported
-11,785.9250
-11,457.0610
-27,525.4310
-12,133.5430
-15,136.8590
Total Expenses
11,785.9250
11,457.0610
20,257.2880
11,566.9600
6,436.8590
Net Income from Continuing & Discontinued Operation
-11,526.3410
-11,121.5200
-27,424.2290
-11,427.5340
-14,413.7880
Normalized Income
-11,526.3410
-11,121.5200
-20,156.0860
-11,042.6069
-6,278.4180
Interest Income
259.5840
335.5410
101.2020
11.6270
3.1740
Interest Expense
--
--
--
0.3620
281.1220
Net Interest Income
259.5840
335.5410
101.2020
11.6270
-277.9480
EBIT
-11,785.9250
-11,457.0610
-20,257.2880
-11,566.9600
-15,133.6850
EBITDA
-11,785.3040
-11,456.8390
-19,468.7930
-10,775.9880
-14,329.9110
Reconciled Depreciation
0.6210
0.2220
788.4950
790.9720
803.7740
Net Income from Continuing Operation Net Minority Interest
-11,526.3410
-11,121.5200
-27,424.2290
-11,427.5340
-14,413.7880
Total Unusual Items Excluding Goodwill
--
--
-7,268.1430
-402.8120
-8,700.0000
Total Unusual Items
--
--
-7,268.1430
-402.8120
-8,700.0000
Normalized EBITDA
-11,785.3040
-11,456.8390
-12,200.6500
-10,373.1760
-5,629.9110
Tax Rate for Calcs
--
--
--
0.0000
0.0001
Tax Effect of Unusual Items
--
--
--
-17.8849
-564.6300
12/31/2020 - 3/7/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PBM Psyence Biomedical Ltd.
1.8500
-9.31%
SLXN Silexion Therapeutics Corp
3.5200
+5.39%
PALI Palisade Bio, Inc.
1.7700
-25.00%
CRDF Cardiff Oncology, Inc.
3.9200
+19.88%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.8100
+2.26%
TRVI Trevi Therapeutics, Inc.
4.1700
+15.83%
IPHA Innate Pharma S.A.
3.0200
+96.10%
CMRX Chimerix, Inc.
2.9500
+0.34%
SXTP 60 Degrees Pharmaceuticals, Inc.
1.4100
-14.55%
CDIO Cardio Diagnostics Holdings, Inc.
1.2600
+5.00%